Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psilocybin occasioned mystical‐type experiences
Edward James, Thomas L Robertshaw, Mathew Hoskins, et al.
Human Psychopharmacology Clinical and Experimental (2020) Vol. 35, Iss. 5
Open Access | Times Cited: 23

Showing 23 citing articles:

Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects
Jacob S. Aday, Alan K. Davis, Cayla M. Mitzkovitz, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 424-435
Open Access | Times Cited: 167
The Therapeutic Potential of Psilocybin
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
Molecules (2021) Vol. 26, Iss. 10, pp. 2948-2948
Open Access | Times Cited: 153
Psychedelics and Psychotherapy
Sandeep M. Nayak, Matthew W. Johnson
Pharmacopsychiatry (2020) Vol. 54, Iss. 04, pp. 167-175
Closed Access | Times Cited: 53
On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review
Richard J. Zeifman, Nikhita Singhal, Leah Breslow, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 436-451
Open Access | Times Cited: 45
N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine
Edward James, Joachim Keppler, Thomas L Robertshaw, et al.
Human Psychopharmacology Clinical and Experimental (2022) Vol. 37, Iss. 3
Open Access | Times Cited: 29
Psychedelic therapies reconsidered: compounds, clinical indications, and cautious optimism
Jennifer Mitchell, B. Anderson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 96-103
Open Access | Times Cited: 21
Psychedelic unselfing: self-transcendence and change of values in psychedelic experiences
Juuso Kähönen
Frontiers in Psychology (2023) Vol. 14
Open Access | Times Cited: 17
Is the Requirement for First-Person Experience of Psychedelic Drugs a Justified Component of a Psychedelic Therapist’s Training?
Nathan Emmerich, Bryce Humphries
Cambridge Quarterly of Healthcare Ethics (2023) Vol. 33, Iss. 4, pp. 548-557
Closed Access | Times Cited: 13
Socio-psychedelic imaginaries: envisioning and building legal psychedelic worlds in the United States
Claudia Schwarz-Plaschg
European Journal of Futures Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 20
The phenomenology of psilocybin’s experience mediates subsequent persistent psychological effects independently of sex, previous experience or setting
Tereza Klučková, M. Nikolič, Filip Tylš, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Psychedelic Mystical Experience: A New Agenda for Theology
Ron Cole‐Turner
Religions (2022) Vol. 13, Iss. 5, pp. 385-385
Open Access | Times Cited: 11
Exploring the Therapeutic Potential of Virtual Reality: A Review on the Simulation of Psychedelic Effects for Treating Psychological Disorders
Mirko Casu, Chiara Farrauto, Giorgia Farruggio, et al.
Deleted Journal (2024) Vol. 6, Iss. 2, pp. 603-617
Open Access | Times Cited: 1
Mystical and Ego-Dissolution Experiences in Ayahuasca and Jurema Holistic Rituals: An Exploratory Study
Robson Savoldi, Antônio Roazzi, Rita Clara de Oliveira Sales
International Journal for the Psychology of Religion (2023) Vol. 33, Iss. 4, pp. 332-360
Closed Access | Times Cited: 4
Experiences With Sacred Mushrooms and Psilocybin In Dialogue: Transdisciplinary Interpretations Of The “Velada”
Antonella Fagetti, Roberto E. Mercadillo
Anthropology of Consciousness (2022) Vol. 33, Iss. 2, pp. 385-411
Closed Access | Times Cited: 6
Psychédéliques, psychothérapie et symbolisation : une revue de littérature dans le champ de la dépression
Etienne Artru, Thomas Rabeyron
L Évolution Psychiatrique (2021) Vol. 86, Iss. 3, pp. 591-616
Open Access | Times Cited: 7
How Level is the 'Cognitive Playing Field'?
Joshua M. Martin, Philipp Sterzer
Philosophy and the Mind Sciences (2022) Vol. 3
Open Access | Times Cited: 5
The History, Legalization and Potentials of Psilocybin-Assisted Psychotherapy
Jeffery Heilman
Journal of Scientific Exploration (2023) Vol. 36, Iss. 4, pp. 623-640
Open Access | Times Cited: 2
The Metaphysics Matrix Questionnaire: the development of an accessible measure of belief change for the general population
Jamie Rennie, Peter Sjöstedt-Hughes, Celia J. A. Morgan
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
Four individuals' experiences during and following a psilocybin truffle retreat in the Netherlands
Anna Lutkajtis
Journal of Psychedelic Studies (2021) Vol. 5, Iss. 1, pp. 22-32
Open Access | Times Cited: 5
The effects of psilocybin on cognition and emotional processing in healthy adults and adults with depression: a systematic literature review
Laura Ramos, Selene Vicente
Journal of Clinical and Experimental Neuropsychology (2024) Vol. 46, Iss. 5, pp. 393-421
Closed Access
Responding to existential distress at the end of life: Psychedelics and psychedelic experiences and/ as medicine
Nathan Emmerich
Neuroethics (2024) Vol. 17, Iss. 3
Open Access
Examining associations between MDMA/ecstasy and classic psychedelic use and impairments in social functioning in a U.S. adult sample
Grant Jones, Joshua Lipson, Erica Wang
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Naturalistic Entheogenics: Précis of Philosophy of Psychedelics
Chris Letheby
(2021)
Open Access
Page 1

Scroll to top